An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E-Null Mice
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000174589.70190.e2
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2005
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)